We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Flexible Robotic System to Offer Best-In-Class Endoscopic Visualization

By HospiMedica International staff writers
Posted on 08 Jan 2024
Print article
Image: The world’s first flexible robotic surgical system will integrate advanced sensor technology (Photo courtesy of EndoQuest)
Image: The world’s first flexible robotic surgical system will integrate advanced sensor technology (Photo courtesy of EndoQuest)

A revolutionary flexible endoluminal robotic system will combine market-leading sensor technology into its visualization component, ultimately improving patient outcomes and redefining a new standard of care in minimally invasive surgery.

EndoQuest Robotics (Houston, TX, USA), a medical device company pioneering the development of innovative endoluminal robotic technologies, and OMNIVISION (Santa Clara, CA, USA), a developer of semiconductor solutions, including advanced digital imaging, and touch display technology, have entered into a partnership to integrate OMNIVISION's OCHFA CameraCubeChip into EndoQuest's Flexible Robotic System.

To address the unmet needs in gastrointestinal (GI) and other endoluminal surgeries, EndoQuest is developing a novel robotic system that offers precision, flexibility, and improved patient outcomes. The system uses proprietary technology to navigate and perform procedures within the body's natural orifices, including transoral and transanal, thus enabling the least invasive interventions and improving the capabilities of healthcare professionals. As compared to conventional open, laparoscopic, or robotic surgery, which requires incisions through healthy tissue to access the site of surgical intervention, EndoQuest’s revolutionary approach minimizes external incisions and related complications. Incorporating OMNIVISION's market-leading sensor technology into the visualization component of EndoQuest’s first-of-its-kind platform will take patient care and surgical visualization to the next level.

"We are excited to be able to incorporate OMNIVISION's market-leading sensor technology into the visualization component of our first of its kind platform," said Kurt Azarbarzin, CEO of EndoQuest Robotics. "We recognize that advanced imaging is essential to enhancing physician capabilities, especially inside the lumen of the gastrointestinal (GI) tract. OMNIVISION's newest technology is ideal for our Flexible Robotic System."

"We are pleased to integrate our OCHFA CameraCubeChip into the EndoQuest Robotics platform," said Tehzeeb Gunja, OMNIVISION's Director of Medical Marketing. "The OCHFA CameraCubeChip is a high-performance visualization solution built with OMNIVISION's PureCel Plus-S pixel technology, with a small 1.008-micron (µm) pixel size, in a 1/8-inch optical format; it features 720x720 resolution at 30 frames per second. The PureCel Plus-S technology enables high full-well capacity, zero blooming and lower power consumption for crisp, clear life-like images. The OCHFA CameraCubeChip comes in a compact 1.075 x 1.075-millimeter (mm) size, with a 5mm to 50mm focus range and 120-degree diagonal field-of-view that is ideal for GI and other endoluminal procedures. It is a medical-grade, trusted component that undergoes comprehensive certification, qualification and testing, taking patient care and surgical visualization to the next level."

Related Links:
EndoQuest Robotics
OMNIVISION

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Bariatric Flip Seat Scale
Detecto 6868
New
Treatment Cart
Avalo Woodblend

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.